London Calling 2025 - Speakers
Speakers
Check out the line up of speakers at London Calling 2025.
Oxford Nanopore Technologies
Carika Weldon
- Job title
- Institution
- CariGenetics, Bermuda
- Biography
Dr. Carika Weldon, PhD, MRSB, FIBMS, is a Bermudian biochemist and Founder & CEO of CariGenetics, the world’s first Caribbean-based genomics company. Prior to this she was a Lecturer at De Montfort University and founded the Bermuda Principles Foundation. Dr. Weldon worked as the Oxford Nanopore Project Manager at the Oxford Genomics Centre at the University of Oxford, UK. In April 2020, called by the Bermuda Government, she was appointed as the Science Advisor to the Premier and Laboratory Director of the government’s COVID-19 lab, which she created. Dr. Weldon was granted a Queen’s Certificate & Badge of Honour for this work.
- Recent publications
Sousa-Luís, R. et al. POINT technology illuminates the processing of polymerase-associated intact nascent transcripts. Mol Cell. 81(9):1935–1950.e6. (2021). DOI: https://doi.org/10.1016/j.molcel.2021.02.034
Liu, Y. et al. Accurate targeted long-read DNA methylation and hydroxymethylation sequencing with TAPS. Genome Biol. 21(54) (2020). DOI: https://doi.org/10.1186/s13059-020-01969-6
Weldon, C. et al. Specific G-quadruplex ligands modulate the alternative splicing of Bcl-X. Nucleic Acids Res. 46(2):886–896 (2018). DOI: https://doi.org/10.1093/nar/gkx1122
Oxford Nanopore Technologies products are RUO. Products labelled/branded as Oxford Nanopore Diagnostics may be RUO or may be regulated as in-vitro diagnostic devices in some jurisdictions, please check individual product labelling. Oxford Nanopore Technologies present the materials of third parties within the user community acknowledging that those materials belong to and are the true statements and representations of those third parties. Oxford Nanopore Technologies make no endorsements of the materials shown and the statements made.
